Entropic Communications

Entropic Biosciences is a UCLA spin-out biotechnology company that has developed a proprietary platform for the rapid assembly of 3D multicellular organoids and functional human tissues. The company's bioinspired technology enables the creation of complex tissue models in less than 24 hours, significantly outperforming traditional hydrogel-based methods in speed and efficiency. This platform is utilized for high-throughput drug discovery, precision oncology, and the development of 3D skin models for testing environmental insults. By facilitating the rapid self-assembly of cells into self-standing tissue, Entropic Biosciences aims to accelerate therapeutic development and enable individualized cancer treatments through surgical biopsy samples.